business
Forget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6
Forget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6
Read full story on Yahoo Finance → More top storiesAlso covered by
Investing.com
UBS cuts Wix.com stock price target on margin pressure to $68
Investing.com
Evercore ISI raises HP Enterprise stock price target on H3C sale
Investing.com
UBS raises Cisco stock price target to $132 on AI order strength
Investing.com
UBS cuts Jack In The Box stock price target to $14 on weak sales
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop